Literature DB >> 15866591

Patterns of ovarian response to gonadotropin stimulation in female carriers of balanced translocation.

Serena H Chen1, Tomas Escudero, Natalie A Cekleniak, David B Sable, Margaret G Garrisi, Santiago Munne.   

Abstract

OBJECTIVE: To determine whether maternal balanced translocation is a risk factor for poor ovarian response to controlled ovarian hyperstimulation (COH).
DESIGN: A retrospective analysis.
SETTING: Private IVF center. PATIENT(S): All couples presenting to a single center for preimplantation genetic diagnosis (PGD) for autosomal balanced translocation in either partner from 1995 through 2001. INTERVENTION(S): Cycle parameters and embryology outcomes were examined and compared between two groups: 61 cycles in 46 women with balanced translocations compared with 42 cycles in 32 women whose male partner had a balanced translocation. MAIN OUTCOME MEASURE(S): Response to ovarian stimulation. RESULT(S): In couples undergoing IVF/PGD to avoid transmission of an unbalanced karyotype, a significantly higher proportion of women carrying balanced translocations (female carrier) responded very poorly (E2 on the day of hCG <1,000 pg/mL) to ovarian stimulation compared to women whose partner had a balanced translocation (male carrier) (23.0% vs. 7.1%). CONCLUSION(S): In couples undergoing IVF/PGD for balanced translocation, the risk for poor response to ovarian stimulation may be increased when the female partner carries the balanced translocation compared to when the male partner carries the translocation. Given significant embryo attrition due to chromosomal imbalance, aggressive stimulation should be considered if the patient does not have risk factors for ovarian hyperstimulation syndrome (OHSS).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866591     DOI: 10.1016/j.fertnstert.2004.11.058

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Are ovarian responses and the number of transferable embryos different in females and partners of male balanced translocation carriers?

Authors:  Mingyue Liu; Zhiqin Bu; Yan Liu; Jinhao Liu; Shanjun Dai
Journal:  J Assist Reprod Genet       Date:  2022-08-04       Impact factor: 3.357

2.  Karyotype analysis in large-sample infertile couples living in Central China: a study of 14965 couples.

Authors:  Yan Liu; Xiang-dong Kong; Qing-hua Wu; Gang Li; Lin Song; Ying-Pu Sun
Journal:  J Assist Reprod Genet       Date:  2013-03-09       Impact factor: 3.412

3.  Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice.

Authors:  Annelien Bredenoord; Wybo Dondorp; Guido Pennings; Christine de Die-Smulders; Bert Smeets; Guido de Wert
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

4.  Clinical Considerations of Preimplantation Genetic Diagnosis for Monogenic Diseases.

Authors:  Xiaokun Hu; Jing Wang; Yubin Li; Yizi Wang; Chenhui Ding; Yanhong Zeng; Yanwen Xu; Canquan Zhou
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

5.  Age and Serum AMH and FSH Levels as Predictors of the Number of Oocytes Retrieved from Chromosomal Translocation Carriers after Controlled Ovarian Hyperstimulation: Applicability and Limitations.

Authors:  Yulia V Shilenkova; Anna A Pendina; Irina D Mekina; Olga A Efimova; Evgeniia M Komarova; Elena A Lesik; Mariia A Ishchuk; Elena M Fedorova; Olga G Chiryaeva; Lubov' I Petrova; Vera S Dudkina; Olga E Talantova; Alexander M Gzgzyan; Igor Yu Kogan
Journal:  Genes (Basel)       Date:  2020-12-25       Impact factor: 4.096

6.  In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing.

Authors:  Chantal B Bartels; Reeva Makhijani; Prachi Godiwala; Alison Bartolucci; John C Nulsen; Daniel R Grow; Lawrence Engmann; Claudio A Benadiva
Journal:  F S Rep       Date:  2020-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.